These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38151884)
1. Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials. Li K; Tan K; Yacovelli A; Bi WG J Oral Rehabil; 2024 May; 51(5):886-897. PubMed ID: 38151884 [TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis. Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934 [TBL] [Abstract][Full Text] [Related]
3. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder. Zhang LD; Liu Q; Zou DR; Yu LF Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229 [TBL] [Abstract][Full Text] [Related]
4. Unclear results for the use of botulinum toxin therapy for TMD pain. Keenan JR Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526 [TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence? Delcanho R; Val M; Guarda Nardini L; Manfredini D J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism. Hosgor H; Altindis S; Sen E J Orofac Orthop; 2024 May; 85(Suppl 1):102-108. PubMed ID: 37843582 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in the management of temporomandibular disorders: a systematic review. Thambar S; Kulkarni S; Armstrong S; Nikolarakos D Br J Oral Maxillofac Surg; 2020 Jun; 58(5):508-519. PubMed ID: 32143934 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials. Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518 [TBL] [Abstract][Full Text] [Related]
9. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. Rezazadeh F; Esnaashari N; Azad A; Emad S BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness of botulinum toxin for temporomandibular disorders: A systematic review and meta-analysis. Saini RS; Ali Abdullah Almoyad M; Binduhayyim RIH; Quadri SA; Gurumurthy V; Bavabeedu SS; Kuruniyan MS; Naseef PP; Mosaddad SA; Heboyan A PLoS One; 2024; 19(3):e0300157. PubMed ID: 38483856 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. Chen YW; Chiu YW; Chen CY; Chuang SK Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597 [TBL] [Abstract][Full Text] [Related]
13. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain. Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Ernberg M; Hedenberg-Magnusson B; List T; Svensson P Pain; 2011 Sep; 152(9):1988-1996. PubMed ID: 21514731 [TBL] [Abstract][Full Text] [Related]
15. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison. Hosgor H; Coskunses FM; Altindis S J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004 [TBL] [Abstract][Full Text] [Related]
16. Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective? Martenot A; Devoti JF; Pons M; Meyer C; Brumpt E; Louvrier A; Bertin E J Stomatol Oral Maxillofac Surg; 2024 Oct; 125(5):101715. PubMed ID: 38013116 [TBL] [Abstract][Full Text] [Related]
17. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex. Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475 [TBL] [Abstract][Full Text] [Related]
18. Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder? de Lima MC; Rizzatti Barbosa CM; Duarte Gavião MB; Ferreira Caria PH Cranio; 2024 Jul; 42(4):421-428. PubMed ID: 34488556 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Ihde SK; Konstantinovic VS Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141 [TBL] [Abstract][Full Text] [Related]
20. Safety of botulinum toxin type A: a systematic review and meta-analysis. Naumann M; Jankovic J Curr Med Res Opin; 2004 Jul; 20(7):981-90. PubMed ID: 15265242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]